Viewing Study NCT00143156


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2025-12-26 @ 10:45 PM
Study NCT ID: NCT00143156
Status: COMPLETED
Last Update Posted: 2021-01-22
First Post: 2005-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A0081071
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators